Get the Stockscreener App
7.62
2.83%
0.21
After Hours:
7.71
0.09
+1.18%
Regenxbio Inc Stock (RGNX) Forecast
The Regenxbio Inc (RGNX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.73, representing a +93.34% increase from the current price of $7.62. The highest analyst price target is $18.66, and the lowest is $10.81.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RGNX Price Target
Average 14.28
(+87.42% Upside)
Is Regenxbio Inc (RGNX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.08 | Neutral |
| STOCH(9,6) | 10.06 | Buy |
| STOCHRSI(14) | 12.53 | Buy |
| MACD(12,26) | -0.5507 | Sell |
| ADX(14) | 16.05 | Neutral |
| William %R | -87.61 | Buy |
| CCI(14) | -115.13 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.604
Sell
|
8.3523
Sell
|
| MA20 |
9.0735
Sell
|
8.8481
Sell
|
| MA50 |
9.5814
Sell
|
9.5734
Sell
|
| MA100 |
10.58
Sell
|
10.60
Sell
|
| MA200 |
13.24
Sell
|
12.32
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RGNX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on RGNX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.08 indicates that RGNX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.06 indicates that RGNX is oversold. This indicates that RGNX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.53 indicates that RGNX is oversold. This suggests that RGNX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.05 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -115.13 indicates that RGNX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term RGNX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Regenxbio Inc financial reports and earnings history, Regenxbio Inc (RGNX) stock could reach $12.18 by 2030, $24.45 by 2040 and $67.81 by 2050. See the projected annual prices until 2050 of the Regenxbio Inc stock below:
- Regenxbio Inc (RGNX) is expected to reach an average price of $5.0063 in 2035, with a high prediction of $10.16 and a low estimate of $5.5363. This indicates an $-34.30% rise from the last recorded price of $7.62.
- Regenxbio Inc (RGNX) stock is projected to chart a bullish course in 2040, with an average price target of $23.98, representing an $214.70% surge from its current level. The forecast ranges from a conservative $25.02 to a sky-high $24.45.
- Our analysts predict Regenxbio Inc (RGNX) to jump 476.69% by 2045, soaring from $41.78 to an average price of $43.94, potentially reaching $40.63. While $41.78 is the low estimate, the potential upside is significant.
- Regenxbio Inc (RGNX) stock is expected to climb by 2050, reaching an average of $64.20, a $742.58% jump from its current level. However, a wide range of estimates exists, with high and low targets of $67.81 and $66.98, respectively, highlighting the market's uncertainty.
Regenxbio Inc Stock (RGNX) Year by Year Forecast
Regenxbio Inc Stock (RGNX) Price Forecast for 2025
Regenxbio Inc Stock (RGNX) is expected to reach an average price of $14.28 in 2025, with a high prediction of $28.39 and a low estimate of $0.1691. This indicates an +87.42% rise from the last recorded price of $7.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.22 | $10.81 | $18.66 | +60.32% |
| February, 2025 | $16.83 | $11.39 | $23.32 | +120.93% |
| March, 2025 | $13.30 | $12.57 | $28.39 | +74.58% |
| April, 2025 | $5.6254 | $0.1691 | $16.95 | -26.18% |
| May, 2025 | $10.13 | $1.38 | $11.28 | +32.99% |
| June, 2025 | $12.69 | $9.2516 | $19.34 | +66.56% |
| July, 2025 | $11.66 | $8.5397 | $18.90 | +53.07% |
| August, 2025 | $12.17 | $9.5387 | $14.95 | +59.74% |
| September, 2025 | $8.2503 | $7.9158 | $15.93 | +8.27% |
| October, 2025 | $3.9629 | $2.7729 | $10.43 | -47.99% |
| November, 2025 | $3.331 | $1.6715 | $6.0719 | -56.29% |
| December, 2025 | $4.8936 | $2.3955 | $6.1336 | -35.78% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2026
The predicted value for Regenxbio Inc (RGNX) in 2026 is set at an average of $15.26. Estimates vary from a peak of $27.17 to a trough of $3.3431, indicating an +100.20% surge from the present price of $7.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $13.44 | $3.3431 | $14.03 | +76.40% |
| February, 2026 | $21.59 | $10.98 | $22.60 | +183.33% |
| March, 2026 | $25.25 | $20.43 | $27.17 | +231.34% |
| April, 2026 | $20.45 | $17.30 | $26.67 | +168.38% |
| May, 2026 | $17.48 | $13.79 | $20.58 | +129.38% |
| June, 2026 | $12.92 | $9.7975 | $18.10 | +69.51% |
| July, 2026 | $14.21 | $9.5146 | $14.84 | +86.47% |
| August, 2026 | $16.01 | $11.71 | $16.97 | +110.07% |
| September, 2026 | $16.51 | $14.35 | $19.35 | +116.66% |
| October, 2026 | $10.16 | $9.7779 | $17.56 | +33.31% |
| November, 2026 | $11.47 | $5.9916 | $12.97 | +50.47% |
| December, 2026 | $21.41 | $11.78 | $25.82 | +180.95% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Regenxbio Inc (RGNX) is $12.27, with a high forecast of $23.90 and a low forecast of $0.6302. This indicates an +60.98% increase from the last price of $7.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $15.97 | $9.3576 | $23.90 | +109.54% |
| February, 2027 | $13.51 | $10.35 | $20.53 | +77.36% |
| March, 2027 | $12.87 | $9.2537 | $14.94 | +68.86% |
| April, 2027 | $8.5453 | $6.3853 | $16.74 | +12.14% |
| May, 2027 | $6.9434 | $4.8494 | $8.2044 | -8.88% |
| June, 2027 | $8.766 | $5.127 | $11.17 | +15.04% |
| July, 2027 | $14.61 | $7.005 | $16.03 | +91.79% |
| August, 2027 | $11.21 | $10.55 | $17.26 | +47.14% |
| September, 2027 | $3.7847 | $0.6302 | $11.73 | -50.33% |
| October, 2027 | $3.3528 | $1.4328 | $6.0583 | -56.00% |
| November, 2027 | $10.22 | $3.2923 | $10.93 | +34.13% |
| December, 2027 | $16.21 | $8.6155 | $18.51 | +112.78% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2028
In 2028, Regenxbio Inc (RGNX) is projected to reach an average price of $9.6634, with a high projection of $16.87 and a low estimate of $2.4542. This indicates an +26.82% rise from the last price of $7.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12.72 | $11.79 | $16.87 | +66.95% |
| February, 2028 | $9.7896 | $5.4951 | $12.96 | +28.47% |
| March, 2028 | $7.3522 | $4.9787 | $10.50 | -3.51% |
| April, 2028 | $6.5503 | $3.5667 | $9.2467 | -14.04% |
| May, 2028 | $6.5129 | $5.5529 | $8.6093 | -14.53% |
| June, 2028 | $7.5209 | $5.9874 | $9.9964 | -1.30% |
| July, 2028 | $7.799 | $6.5805 | $9.0145 | +2.35% |
| August, 2028 | $5.7016 | $5.2766 | $10.36 | -25.18% |
| September, 2028 | $3.8297 | $3.1152 | $6.9219 | -49.74% |
| October, 2028 | $4.4978 | $2.4542 | $6.2578 | -40.97% |
| November, 2028 | $5.6603 | $2.8958 | $7.8768 | -25.72% |
| December, 2028 | $6.1884 | $4.4284 | $6.9584 | -18.79% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2029
The 2029 price forecast for Regenxbio Inc Stock (RGNX) is $9.0085 on average, with a high prediction of $17.71 and a low estimate of $0.3088. This represents an +18.22% increase from the previous price of $7.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.521 | $4.0115 | $6.7075 | -27.55% |
| February, 2029 | $4.9291 | $3.8946 | $6.3655 | -35.31% |
| March, 2029 | $4.8172 | $3.9672 | $5.8836 | -36.78% |
| April, 2029 | $3.3852 | $2.1307 | $5.2617 | -55.57% |
| May, 2029 | $5.4578 | $0.3088 | $5.8578 | -28.38% |
| June, 2029 | $7.5459 | $5.0123 | $8.6269 | -0.97% |
| July, 2029 | $6.084 | $5.864 | $9.3849 | -20.16% |
| August, 2029 | $0.7766 | $0.5266 | $6.8885 | -89.81% |
| September, 2029 | $6.1246 | $0.3511 | $8.9901 | -19.62% |
| October, 2029 | $10.82 | $5.8992 | $17.71 | +41.96% |
| November, 2029 | $4.9853 | $4.6153 | $11.52 | -34.58% |
| December, 2029 | $13.22 | $4.5398 | $6.4939 | +73.43% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2030
Regenxbio Inc Stock (RGNX) is expected to reach an average price of $12.05 in 2030, with a high forecast of $23.31 and a low forecast of $0.7834. This signifies an +58.07% surge from the last price of $7.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.6748 | $12.24 | $12.18 | +26.97% |
| February, 2030 | $10.03 | $9.7148 | $9.8387 | +31.61% |
| March, 2030 | $16.00 | $9.6474 | $12.16 | +110.01% |
| April, 2030 | $22.32 | $21.32 | $21.31 | +192.93% |
| May, 2030 | $20.36 | $18.76 | $21.44 | +167.21% |
| June, 2030 | $14.95 | $18.20 | $16.56 | +96.13% |
| July, 2030 | $16.78 | $18.30 | $18.19 | +120.22% |
| August, 2030 | $12.84 | $14.36 | $12.17 | +68.55% |
| September, 2030 | $8.8176 | $14.08 | $12.31 | +15.72% |
| October, 2030 | $0.5126 | $3.5324 | $8.1905 | -93.27% |
| November, 2030 | $25.27 | $0.7834 | $14.48 | +231.58% |
| December, 2030 | $24.61 | $21.99 | $23.31 | +222.97% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):